The global veterinary CRO and CDMO market size is anticipated to reach USD 11.42 billion by 2030 and is anticipated to expand at a CAGR of 9.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing expenditure on animal healthcare, growing inclination toward outsourcing processes such as research and development, and rising demand for effective animal health solutions worldwide are expected to drive market growth.
Significant investments in developing safe and efficient vaccines to prevent life-threatening diseases in livestock animals, growth in demand for novel medicines designed for companion animals, and an increase in pet ownership influence this market. In addition, the technical competence offered by CROs, advanced equipment capabilities of CDMOs, improved supply chain management, and easy distribution contribute to growth.
Rising collaborations among animal health companies and CROs or CDMOs for various applications, including clinical trials, research, discovery, and development, are likely to develop lucrative opportunities. Noteworthy investments by key market participants in portfolio enhancement, capacity expansion, and improved processes are projected to aid growth over the forecast period.
Request a free sample copy or view report summary: Veterinary CRO And CDMO Market Report
Livestock animals segment dominated the global market with more than 55% of revenue share in 2024 owing to growing concerns regarding the safety of meat and other byproducts associated with livestock animals, frequent outbreaks of novel diseases, and increasing demand for effective vaccines
The companion animals segment is expected to experience the fastest growth due to the significant increase in the adoption of various animal health products, such as medicine and devices specifically designed for pets
The development segment held the largest revenue share of the market in 2024, owing to the rising focus of multiple animal health companies on developing innovative products related to animal health and nutrition.
The discovery segment is expected to experience the fastest growth from 2025 to 2030, owing to increasing investment in research activities related to animal health products
In terms of application segment, medicine segment accounted for the highest market revenue share in 2024
North America dominated the global industry in 2024, owing to its strong pharmaceutical and biotechnology industry, presence of multiple CROs and CDMOs, and growing expenditures on animal health
For the purpose of this report, Grand View Research has segmented the veterinary CRO and CDMO market on the basis of animal, service, application, and region:
Veterinary CRO And CDMO Animal Outlook (Revenue, USD Million; 2018 - 2030)
Companion Animals
Livestock Animals
Veterinary CRO And CDMO Service Outlook (Revenue, USD Million; 2018 - 2030)
Discovery
Development
Early Phase/Preclinical
Late phase/Clinical
Manufacturing
Packaging & Labeling
Market Approval & Post Marketing
Veterinary CRO And CDMO Application Outlook (Revenue, USD Million; 2018 - 2030)
Medicine
Pharmaceuticals
Biologics
Others
Medical Devices
Veterinary CRO And CDMO Region Outlook (Revenue, USD Million; 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Columbia
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Veterinary CRO and CDMO Market
Fortrea
Charles River Laboratories
Clinvet (Clinglobal)
KLIFOVET GmbH (Argenta Group)
OCRvet (Clinglobal)
Knoell – Triveritas
Veterinary Research Management
VETSPIN SRL
Inotiv
IDEXX
Vetio
TriRx Pharmaceutical Services
"The quality of research they have done for us has been excellent..."